Hemostasis Devices
Summary
This chapter contains sections titled:
-
The ideal vascular hemostasis device
-
Origin of FDA concern with the postmarket performance of hemostasis devices
-
FDA study to evaluate the risk associated with hemostasis device use
-
Possible reasons for FDA findings of apparent protective effects of hemostasis devices
-
Follow-up FDA study to assess the safety of hemostasis devices
-
Conclusion
-
References